Metronomic doses and drug schematic combination response tested within microfluidic models for the treatment of breast cancer cells (JIMT-1).
G. I. Rosero, G. Pattarone, A. Penaherrera, J. F. Pilz, J. Bödecker, B. Lerner, R. Mertelsmann, M. Perez, M. Follo
The paper tests metronomic chemotherapy and drug combinations in microfluidic models to study breast cancer cell responses and death mechanisms.
bioRxiv · Jul 16, 2020 · PreprintCancer Biology